Robotic Partial Nephrectomy May Be a Viable Option for Large Renal Tumors
Robotic partial nephrectomy offers similar oncologic outcomes to robotic radical nephrectomy, but is associated with better preservation of renal function.
NEWS
LATEST NEWS
Behavioral Therapy Superior to Drugs Alone for Urinary Incontinence
Behavioral therapies relieve stress, urgency, and mixed urinary incontinence (UI) more effectively than drug monotherapies in nonpregnant women. In a new systematic review and network meta-analysis (NMA) of 84 randomized trials published in the Annals of Internal Medicine, most interventions including combination therapies improved or resolved women’s symptoms better than no treatment, whether sham or…
TRT Speeds Potency Recovery After Prostate Surgery
In a study, all men who received testosterone replacement therapy within 1 year of robot-assisted radical prostatectomy had full potency recovery at 24 months.
TRT Reduces Post-RARP Recurrence Risk in Low-Risk Prostate Cancer
Testosterone replacement therapy prolonged time to disease progression among men who underwent radical surgery for localized prostate cancer.
Metabolic Syndrome Increases Risk of Kidney Stone Recurrence
Kidney stone recurrence risk increases along with the number of metabolic syndrome components, which include abdominal obesity, hypertension, elevated fasting glucose, low high-density lipoprotein, and elevated triglycerides.
Bladder Cancer Linked to Early Menopause in Smokers
Among women with a history of smoking, menopause onset at age 45 or younger is associated with a 66% higher risk of bladder cancer compared with onset at age 50 or older.
Bladder Cancer Surgery Delay Increases Death Risk
Patients who undergo radical cystectomy for MIBC more than 12 weeks from diagnosis are at increased risk of death, regardless of whether they receive neoadjuvant chemotherapy.
OCR Probes HIPAA Impediments to Care Coordination
In addition to other input, the federal Office for Civil Rights wants to know how the privacy rule might be amended to encourage information sharing among providers.
Drug Treats Hyperphosphatemia Without Binding Phosphate
In a phase 3 trial, tenapanor, which reduces paracellular phosphate transport in the intestine, lowered elevated serum phosphorus in patients on hemodialysis.
Burden, Access and Disparities in Kidney Disease
Kidney disease is a global public health problem, affecting over 750 million persons worldwide.1,2 The burden of kidney disease varies substantially across the world, as does its detection and treatment. In many settings, rates of kidney disease and the provision of its care are defined by socio-economic, cultural and political factors leading to significant disparities.3 World Kidney…
Want to read more?
Please login or register first to view this content.
Next post in Urinary Incontinence
